Swiss biopharmaceutical company Lonza Group has completed the acquisition of HansaBioMed Life Sciences OU, an Estonian pharmaceutical company.

The acquirer company expects the transaction to help develop next-generation research, therapeutic and diagnostic applications based on exosomes.

Shandong Buchang Pharmaceutical has completed the acquisition of Tonghua Guhong Pharmaceutical .

Both companies involved in the acquisition are pharmaceutical firms based in China.